Drug price cuts: what is Trump planning and what will it mean for big pharma?
The GuardianTuesday, May 13, 2025 at 10:14:10 AM
President Donald Trump has ordered sweeping cuts to US prescription drug prices, aiming to align them with prices in other developed countries. The move, targeting slimming drugs among others, initially caused a drop in pharmaceutical stocks but later rebounded amid skepticism about implementation.
What This Means: This action reflects ongoing efforts to address high drug costs in the US, but market reactions suggest uncertainty about its feasibility and impact on the pharmaceutical industry. If implemented, it could reshape pricing structures and industry profits, though political and legal challenges may arise.
— Curated via WP Now’s AI editorial system
